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Identification and characterization of novel proteins from a rare Australian 
elapid snake Drysdalia coronoides 
Partial transcriptome from the venom gland of a rare Australian elapid snake 
Drysdalia coronoides, whose venom composition was not known, was elucidated by 
cDNA library approach and the results were corroborated by determining proteome 
from the crude venom of the snake. Three novel proteins belonging to three finger 
toxin (3FTx) super-family of the snake venom proteins were identified. They consist 
of three clusters represented by the clones 13A, 342A and 513V5. One of them, 
named drysdalin, possesses distinct structural features predicted by online server I-
Tasser, and was chosen for functional and structural characterization.  
Drysdalin was expressed in E. coli followed by affinity chromatography, 
reverse phase HPLC and refolding. It showed dose-dependent and time-dependent 
neurotoxicity in mice with LD50 of 0.775 mg/kg. It was found to be an irreversible 
blocker of muscle-type and neuronal-type nicotinic acetylcholine receptors (nAChRs) 
with EC50 of 37 nM (~2.8 fold less than α-bungarotoxin) and 27 nM, respectively. 
These data were in stark contrast to the substitutions of functionally conserved 
residues which would lead to the decrease in binding affinity to nAChRs. Our data 
suggest that despite these substitutions, there are some structural changes in drysdalin 
that might have prevented the loss of binding affinity. The attempts to solve three-
dimensional structure of drysdalin by X-ray crystallography and NMR were initiated 
because the C-terminus of drysdalin was predicted to acquire a unique fold. The 
protein could not crystallize. However, 2D-NMR spectrum acquired with 15N-labeled 
 viii 
 
drysdalin could indicate the reasons for failure of crystallization attempts. The protein 
sample used for 2D-NMR was suspected to exhibit heterogeneity and/or flexibility. 
These results will help in future experimental designs for structural characterization 
of drysdalin. 
The gene structures of the differentially expressed, closely related isoforms of 
drysdalin were studied by genome walking approach. The promoter regions of the 
genes encoding these isoforms were highly similar with several random mutations 
sharing no relation to their abundance in the transcriptome. This suggests that cis 
elements in the proximity of the gene are not responsible for the differential 
expression of these isoforms.  
The second novel protein encoded by clone 342A exhibited a shorter loop II 
lacking two of the critical residues implicated in binding to nAChRs. Therefore, this 
3FTx is expected to have altered pharmaco-physiological properties. The third novel 
protein encoded by clone 513V5 was identified from the genomic DNA. This search 
was prompted due to the identification of a truncated clone 513A in the cDNA 
library. Genomic DNA PCR revealed that 513V5 had a different open reading frame 
than 513A transcript due to an insertion of 7 bp in exon II. Also, it had different exon-
intron boundary than other 3FTxs. These results imply the significance of deciphering 
snake genome to search for new venom proteins.  
Our study has significantly contributed to the field of snake venom research 
with novel toxins identified from a combined transcriptomics, proteomics and 
genomic approach. This work opens new avenues for various biochemical and 
biophysical studies that may have biomedical applications in the long-term. 
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Snakes have fascinated scientists from different areas of research ranging from 
biodiversity to genomics, proteomics, and drug development. It is the venom that 
makes snakes the organism of choice for research by various laboratories world 
wide. Snake venom has long been known to be employed in traditional Indian, 
Chinese and Arabian medicine. Over the years, the perception regarding venom 
has changed drastically from that of a deadly weapon to a pharmaceutically 
important cocktail of bioactive proteins and polypeptides that act as lead 
molecules for therapeutics development [1-3].  
Snakes evolved from burrowing lizards during lower cetaceous period 
(~100-150 million years ago) [4]. There are about 2,930 species of snakes 
distributed on every continent except Antarctica, islands of Ireland, Iceland and 
New Zealand [5, 6]. They have successfully colonized various habitats and feed 
on small animals including lizards, snakes, rodents, small mammals, birds, eggs 
and insects [7].  
Venomous snakes  
Around 1300 species of snakes are known to be venomous [2]. The venomous 
snakes appeared during the Miocene period (less than 30 million years ago) which 
saw drastic changes in prevailing environmental conditions including 
development of more open habitats (savannahs), and radiation of rodents and 
other potential prey species. This led primitive snakes with slow locomotion and 
active immobilization strategy (i.e constriction) to adapt to rapid locomotion and 
passive immobilization (i.e. pursuit and envenomation) [8]. During this period, 
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the Duvernoy’s glands, the first venom producing apparatus were evolved. 
However, at later stages, these glands became hypertrophied and evolved to form 
specialized venom glands. Venomous snakes are classified into five families [9] : 
Colubridae, Viperidae, Crotalidae, Elapidae and Hydrophidae (Table 1.1). Not all 
of them are dangerous to humans. Colubridae, the largest snake family (~1000 
species) produce small volumes of venom and have poorly developed venom 
delivery apparatus [10]. Therefore, most of the snakes of this family are harmless 
except a few like the African Boomslang (Dispholidus typus).  
Drysdalia coronoides; a rare Australian elapid 
Australian elapids are considered to be the most toxic snake species of the world, 
with all the top 10 and 19 of the top 25 elapids with known LD50s residing 
exclusively on this continent [11]. The venomous terrestrial snakes of the 
Elapidae family have undergone an extensive radiation in Australia [12]. Elapid 
snake genus Drysdalia from southern Australia is a group of rare snakes 
comprising three species, namely, D. coronoides, D. mastersi and D. rhodogaster 
[13]. These viviparous snakes live in a wide variety of climatic conditions. For 
example, D. coronoides, (Figure 1.1A) the smallest of all, occupies the most 
extensive geographical distribution   (Figure 1.1B). It is the only species found in 
Tasmania [14] where it is also referred to as ‘whip-snake’[15]. It is a small 
slender snake which grows to about 40 cm in length [16]. Its body color varies 










Figure 1.1 Drysdalia coronoides and its geographical distribution. (A) The 
‘white-lipped snake’ (photo provided by Mr. Peter Mirtschin, Venom Supplies 
Pty. Ltd., Australia.). (B) The regions (blue) in the Australian continent where the 
snake can be found. The map downloaded from the URL: 
http://schools.look4.net.nz/geography/country_information/outline_maps/australia 
and modified to show the distribution. 
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The snake is easily recognized by the thin white stripe running along its upper lip, 
continuing along the side of the head, fading out along the neck and hence the 
name ‘white-lipped snake’ (Figure 1.1A) It feeds almost exclusively on scincid 
lizards and frogs [14]. There are no reports of this snake biting humans. 
Snake venom 
Snake venom is produced in a highly developed secretory organ called venom 
gland (a modified parotid salivary gland of other vertebrates) [4]. This gland is 
situated on each side of the head below and behind the eye, wrapped with a 
muscular sheath (Figure 1.2). Venom is stored in large alveoli before getting 
channelled to the tubular fang through a duct from where it is ejected [17]. 
Venom composition 
The peptides and the proteins constitute over 90% of the dry weight of the venom. 
Minor non-protein compounds present in the venoms include metal ions, lipids, 
nucleic acids, carbohydrates and amines [18, 19]. Magnesium, calcium and zinc 
are the most common metal components, while copper has been detected in 
certain venoms. These metal ions are mainly associated with the proteins and are 
presumed to be enzyme cofactors [20]. Also, venoms from some snakes, e.g. 
mamba (Dendroaspis ssp.), contain high levels of acetylcholine [21].  
Venom proteins are used mainly to immobilize and kill the preys and 
predators as well as to support the digestion of the food swallowed by the snake 
[22]. Therefore, the venom composition varies in different snake families as well 
as within a family depending on the feeding habits, geographical location and 











Figure 1.2 Snake fangs and the venom gland. Cartoon representations showing 
the location of venom gland in the snake’s head and close look of venom ejection 







Snake venoms are rich in enzymes. More than 20 different enzymes from snake 
venoms have been known and their distribution varies with the family of snakes. 
For example, viperid and crotalid venoms are primarily enzymatic (80–95%), 
while elapids contain relatively lower amounts (25–70%) followed by hydrophid 
venoms with lowest amounts of enzymatic proteins (~20%) [2]. They are 
generally 13 to 150 kDa proteins. These enzymes exert various pharmacological 
activities listed in Table 1.2.  The major components are: phospholipases A2 
(PLA2s) [26], L-amino acid oxidase (LAO) [27], serine proteases [28-30], snake 
venom metalloproteases (SVMPs) [31, 32], acetylcholinesterases (AChEs) [33], 
Venom factors (VFs) [34, 35] and phosphodiesterases (PDEs) [22, 36].  
Non-enzymatic proteins 
Non-enzymatic toxins range around 1 to 25 kDa and they act by targeting various 
physiological systems (Table 1.3). They potentiate the assault caused by 
enzymatic components on the prey. They include: three-finger toxins (3FTxs) 
[37-40], serine protease inhibitors (SPIs) [41], C-type lectin-related proteins 
(CLPs) [42], helveprins/CRISPs [43-45], sarafotoxins [46, 47], waprins [48], 
disintegrins [49], vespryns [50], nerve growth factors (NGFs) [51], bradykinin-
potentiating peptides (BPPs) [52] and natriuretic peptides (NPs) [53]. Among all 
the non-enzymatic components, 3FTx super-family is of peculiar interest for the 























Table 1.3 (continued)... 
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Three-finger toxin family 
Three-finger toxin (3FTx) family, a well-characterized non-enzymatic super-
family of snake venom proteins, is found abundantly in the venoms of elapids 
(cobras, kraits and mambas) and hydrophids (sea snakes and sea kraits) [54]. 
However, recently, 3FTxs have also been found in the venoms of colubridae [55-
57] and crotalidae (rattlesnakes) family of snakes [58, 59]. Based on the length of 
polypeptide chain and number of disulfide bonds, they are broadly classified as 
short-chain (generally, 60-64 aa) and long-chain (generally, 66-75 aa) toxins with 
four and five disulfide bonds, respectively [39] (Figure 1.3). However, some 
proteins, not withstanding this length of polypeptides, have been reported, e.g. 
pseudonajatoxin b (82 aa) and denmotoxin (77 aa) isolated from the venoms of 
Pseudonaja textilis [60] and  Boiga dendrophila [55], respectively. In such cases, 
they are placed under respective classes based on the conserved Cys-pairing. The 
proteins under investigation in this thesis (see chapter 2 and chapter 6) are also 
exceptions to these lengths. The 3FTxs have been further classified based on their 
functions and minute differences in their structure (described below). The unique 
characteristic of the members of this family is their distinct fold referred to as 
‘3FTx fold’ that consists of three adjacent β-sheeted loops, projecting from a 
globular, hydrophobic core cross-linked by conserved intra-molecular disulfide 
linkages (Figure 1.4). Despite sharing similar structure they have been known to 
exhibit diverse functions with active sites distributed variably on all the three 








Figure 1.3 Multiple sequence alignment of short-chain and long-chain toxins. The conserved Cys residues are shaded in black. 
The conserved Cys-pairing and segments corresponding to each loop of both the classes are shown above the sequence alignments.  
The source organisms of the proteins aligned are as follows: Toxin-α (Naja nigricollis), NmmI (N. mossambica), Erabutoxin b (Ebx; 
L. semifascita), α-cobratoxin (Cbtx; N. Kaouthia), α-bungarotoxin (Bgtx; Bungarus multicinctus). The figure has been reproduced 
with permission from Dr. Selvanayagam Nirthanan, Senior Lecturer, School of Medical Science, Griffith University Gold Coast 





Figure 1.4 Functional diversity of 3FTxs. Three-dimensional structures of 
3FTxs isolated from various snake venoms are shown. The protein names with 
PDB codes and source organisms of the proteins are as follows: (A) Neurotoxins: 
Erabutoxin (3EBX; Laticauda semifasciata), (B) α-cobratoxin (2CTX; Naja 
kaouthia), (C) κ-bungarotoxin, a dimer (1KBA; Bungarus multicinctus) and (D) 
Candoxin (1JGK; Bungarus candidus). (E) Fasciculin (1FSS; Dendroaspis 
angusticeps) (F) Muscarinic toxin 2 (1FF4; D. angusticeps) (G) Cardiotoxin 
(2CRT; Naja atra) (H) FS2 (1TFS; D. polylepis) (I) Dendroaspin (1DRS; D. 
jamesoni kaimosae). The Cys residues are represented by ball and stick model and 
disulfide linkages as yellow sticks. Functionally important residues of the toxins 




Generally, all the 3FTxs are monomers except a few, e.g. κ-bungarotoxin (Figure 
1.4C), haditoxin (both non-covalent homodimers) and irditoxin (a covalent 
heterodimer) isolated from the venoms of Bungarus multicinctus [62], 
Ophiophagus hannah [63] and Boiga irregularis [64], respectively. 
Neurotoxins 
The 3FTxs that interfere with cholinergic transmission at post-synaptic sites in the 
peripheral and central nervous systems are called neurotoxins. They constitute the 
largest group of 3FTx family. Based on their receptor selectivity, they are broadly 
classified as α-neurotoxins, κ-toxins and muscarinic toxins that target muscle 
nicotinic acetylcholine receptor (nAChR) [65], neuronal nAChR [66] and various 
subtypes of muscarinic acetylcholine receptor (mAChR) [67], respectively.  
α-neurotoxins 
Among all the neurotoxins, α-neurotoxins are the largest and well characterized 
(structurally and functionally) group of toxins. Snake venom α-neurotoxins are 
the potent competitive antagonists of the nAChRs, the gated ion-channels present 
at the skeletal muscle neuromuscular junction. They inhibit acetylcholine (ACh) 
binding to the receptor, resulting in the blockage of neuromuscular transmission 
[68-70]. This action leads to paralysis of skeletal muscles including diaphragm 
and induce death as a result of respiratory arrest [71, 72]. These symptoms 
resemble the neuromuscular blocking effects of the plant alkaloid d-tubocurarine 
(although with ~15-20-fold higher affinity and poor reversibility of action) and 
hence are also known as ‘curaremimetic neurotoxins’ [73].  The structure-
function relationships of α-neurotoxins have been well established by both 
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chemical modification and genetic engineering approaches.The functional site of 
Erabutoxin (Ebx), a short-chain neurotoxin (SNTx) from the venom of the sea 
snake Laticauda semifasciata has been determined by site-directed mutagenesis 
approach [74]. The functional site in the toxin spans over all the three loops 
covering surface of approximately 680 Å2 consisting of three polar clusters – 
Lys27-Glu38 and Arg33-Asp31 in loop II, Glu7-Gln10 in loop I, which in turn 
interact with a hydrophobic cluster, Trp29-Ile36 in loop II (Figure 1.4A). The 
only residue establishing the contact between loop I and loop II is Ser8. In loop 
III, however, Lys 47 is the only functionally important residue. These critical 
residues are distributed on the bottom tips of all the three loops in the toxin. 
Similar studies on α-cobratoxin (Cbtx), a long-chain neurotoxin (LNTx) isolated 
from the venom of Naja kaouthia has provided insights into the functional site 
(approximately 880 Å2) that resides mostly in loop II of the toxin (Figure 1.4 B) 
[75]. This site consists of Lys23, Trp25, Asp27, Phe29, Arg33 and Arg36 K49 
from loop II and, Lys 49 and Phe65 belonging to loop III and C-terminal tail, 
respectively. It is important to note that the functional residues have structurally 
equivalent counterparts in both the toxins (SNTx and LNTx) lying mostly in loop 
II. However, three major positions at which the functional sites of these two 
toxins vary are: 
� Glu38 in Ebx is crucial for its activity but Asp38 in Cbtx is not  
� Loop I of Ebx but not of Cbtx, is critical for binding to the receptor  
� The extra fifth disulfide linkage at the second loop II in Cbtx confers specificity 
to neuronal α7 nAChR [76]. 
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Atypical long-chain neurotoxins 
These neurotoxins are 69 amino acid residues long neurotoxins isolated from the 
sea snake Laticauda semifasciata (Lc-a and Lc-b) (Figure 1.5) [77]. They possess 
only the four conserved disulfide linkages, in stead of five like a typical LNTx, 
and hence the name. They have high affinity for the Torpedo nAChR but bind 
poorly to neuronal α7 nAChRs, probably due to absence of the fifth disulfide 
bridge at the tip of loop II [76, 78]. 
Non-conventional neurotoxins 
Non-conventional toxins consist of 62–68 amino acid residues and five disulfide 
linkages. In this aspect they resemble the LNTxs, but differ in the presence of the 
fifth disulfide linkage in loop I instead of loop II (Figure 1.5) [79, 80]. Due to 
their reduced lethality as compared to other α-neurotoxins they have also been 
known as ‘weak toxins’ [81]. But isolation of γ-bungarotoxin from the venom of 
Bungarus multicinctus that has LD50 value of 0.15 mg/kg, [82] comparable to 
other α-neurotoxins, led to a renaming of this group of 3FTxs as ‘non-
conventional toxins’ [79, 83].  Candoxin is one of the well studied non-
conventional toxin isolated from the venom of Bungarus candidus (Malayan 
krait) (Figure 1.4D) [80, 84]. It produces readily and completely reversible 
blockage of chick biventer cervicis muscle preparations while irreversibly blocks 
rat neuronal α7 nAChRs at nano molar range. As mentioned previously, fifth pair 
of disulfide bond in loop II of long-chain neurotoxins is thought to be important 
for binding to the neuronal α7 [76, 78]receptors.  But, in candoxin the fifth 








Figure 1.5 Multiple sequence alignment of atypical long-chain neurotoxins and non-conventional neurotoxins. The conserved 
Cys residues are shaded in black. The conserved Cys patterns and segments corresponding to each loop of both the classes are shown 
in thin and thick black bars, respectively above the sequence alignments. The source organisms of the proteins aligned are as follows: 
Lc-a and Lc-b (Laticauda colubrina), candoxin (Bungarus candidus). The figure has been reproduced with permission from Dr. 




This clearly shows that although non-conventional toxins and LNTxs share 
common scaffold there may be additional unidentified molecular targets 
recognized by non-conventional toxins. 
κ-neurotoxins 
Snake venom κ-neurotoxins, e.g. κ-bungarotoxin isolated from the venom of 
Bungarus multicinctus is 66 amino acid residues long and has five disulfide bonds 
with Cys-pairing similar to LNTxs. It has a shorter C-terminal tail like SNTxs 
[66, 85]. This group of toxins  bind specifically to neuronal α3β4 nAChR [66] and 
is the first homodimeric 3FTx reported (Figure 1.4C) [62]. However, there is no 
clear evidence to suggest role played by the dimer in binding to the receptor. 
Hannalgesin 
Hannalgesin is a 3FTx isolated from the venom of Ophiophagus hannah that 
exhibits potent neurotoxic as well as analgesic activity [86]. Blocking of this 
analgesic effect by naloxone and L-NGnitro-arginine methyl ester indicated the 
possibility of involvement of opioid and nitric oxide systems, respectively. The 
analgesic site of this protein was identified by synthesis of a short peptide 
(designed based on “proline-bracket” hypothesis [82]). 
Fasciculins 
 
The first Fasciculin, a 61 amino acid residues long protein with four disulfide 
bridges was isolated from the venom of Dendroaspis angusticeps (eastern green 
mamba) [87]. Later, its closely related proteins were also isolated from the 
venoms of  other species of genus Dendroaspis (Figure 1.5 E) [88]. They are 
potent inhibitors of the enzyme acetylcholinesterase (AChE) which is primarily 
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involved in the termination of neurotransmission impulse at cholinergic synapses 
by hydrolyzing the neurotransmitter ACh. Inhibition of AChE leads to 
generalized, long-lasting fasciculation of skeletal muscles as a consequence of 
accumulation of ACh in the synaptic cleft [89]. The residues involved in the 
complex formation of FAS II with AChE are present on loop I and II of the toxin 
(Figure 1.4E). 
Muscarinic toxins 
Muscarinic toxins (MTs) are 63 to 66 amino acid residues long proteins with eight 
Cys residues and four disulfide linkages (Figure 1.4F), isolated from the venom of 
Dendroaspis angusticeps (African green mamba) [90]. They are the first reported 
protein toxins that bind to the muscarinic acetylcholine receptors (mAChRs) and 
were named so [91]. Five subtypes of mAChRs (M1 to M5) have been known so 
far that belong to a large family of cell surface proteins called G protein coupled 
receptors (GPCRs). The mAChRs control myriads of physiological processes [67, 
91] and have been implicated as important drug targets for neurological disorders 
like schizophrenia, depression and Parkinson’s and Alzheimer’s diseases [92, 93]. 
Currently, there are nearly 100 conventional small molecular muscarinic 
antagonists and most of them bind with nearly equal affinity to two or three of 
mAChR subtypes. None of these antagonists is specific for just one subtype of 
mAChR [93], thus it was difficult to define the functional importance of the 
individual subtypes of mAChRs [67, 94]. MTs became the first highly subtype-
specific agonists/antagonists isolated from the venoms of various mambas that 
proved to be invaluable research and diagnostic tools for the biomedical 
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applications. The large size of the toxin was speculated to be the reason for 
specificity of MTs for various subtypes of mAChRs, that enables the toxin’s 
interactions to the highly variable extracellular loop regions of the GPCRs and 
thus differentiating between the subtypes [91]. 
Cardiotoxins (CTxs) 
The members of this group of 3FTxs are about 60 amino acid residues long with 
four disulfide bonds and are predominantly found in the venoms of most elapid 
(especially cobras) snakes (Figure 1.4G). Their high lethality attributed to their 
diverse pharmacological effects on the prey is the leading cause of death [95]. 
They have been reported to exhibit activities including altered polarization status 
of the membranes of various cells [96-99], inhibition of resorption of bones [100], 
lysis of several cell-types [101-103], lipolysis and steroidogenesis [104]. Despite 
encompassing this broad spectrum of pharmacological activities, no common 
molecular target or mechanism of action has yet been elucidated for CTxs. The 
functional site of CTxs has been proposed to be the continuous hydrophobic patch 
starting from the tip of loop I and covering most parts of loops II and III, spanning 
nearly 40% of the molecular surface [105]. Recently, a CTx isolated from the 
venom of Ophiophagus hannah (king cobra) induces reduction in heart rates 
(bradycardia) in anesthetized rats and isolated perfused rat hearts (in contrast to 
tachycardia induced by conventional CTxs). This CTx has been shown to 
specifically bind to β-adrenergic receptors that are responsible for the regulation 
of the cardiac contraction and hence is named ‘β-cardiotoxin’ [106]. It is the first 
reported antagonist of β-adrenergic receptor. Use of conventional (synthetic) β-
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adrenergic receptor antagonists as drugs of choice for treatment of cardiovascular 
diseases suffer from adverse side effects [107-109]. Therefore, β-cardiotoxin is a 
promising molecule and understanding its structure-function relationships will 
lead to novel therapeutic design for the treatment of cardiovascular diseases.  
Calciseptine and FS2 toxin 
Calciseptine and related FS2 toxins, isolated from the venom of Dendroaspis 
polylepis (black mamba) are 60 amino acid residues long with four disulfide 
linkages (Figure 1.4H). They selectively inhibit L-type Ca2+ channels in heart and 
other tissues [110-112]. Calciseptine and related FS2 toxins differ at only three 
positions [113]. Additional isoforms of these toxins isolated from the venoms of 
D. angusticeps (green mamba) and D. jamesoni (Jameson’s mamba) inhibit L-
type Ca2+ channels completely in the cardiovascular system but partially in the 
neuronal system. The functional site of this protein was located as the sequence 
between Pro42 and Pro47 residues, identified by “proline-bracket” hypothesis 
[40] (Figure 1.4H). 
Dendroaspin or mambin 
Dendroaspin, also referred to as S5C1 [114] or mambin [115] is 59 amino acid 
residues long and has four disulfide linkages (Figure 1.4I). It was isolated from 
both Dendroaspis jamesoni kaimosae (eastern Jameson’s mamba) and D. viridis 
(western green mamba) venoms [116]. It has Arg-Gly-Asp (RGD)-motif that 
interacts with a platelet glycoprotein GP IIb-IIIa (also known as αIIbβ3, an integrin 
receptor) and inhibits platelet aggregation at nanomolar range [115]. RGD motif 
is important for the binding of many extracellular matrix (ECM) proteins to 
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integrin receptors. Dendroaspin and disintegrins (a group of proteins isolated from 
viperidae snake venoms) compete with the binding of ECM proteins to their 
receptors, and thus act as potent inhibitors of cell-cell and cell-matrix interactions. 
However, dendroaspin and disintegrins do not have any structural or sequence 
similarity except for the presence of the RGD tripeptide motif [117]. 
Non-venom proteins with ‘3FTx’ fold 
The ‘3FTx fold’ is not just restricted to the toxins from snake venom. The 3FTx 
homologues from non-toxin sources (encompassing a diverse range from plants to 
mammals) sharing significant structural similarity to the ‘3FTx fold’ of snake 
venom proteins have been reported (Figure 1.6) [39]. They are promiscuously 
distributed in various cell-types in different organisms. ‘3FTx fold’ is adopted by 
non-toxic proteins from Ly-6 family of glycerophosphoinsitol -linked mammalian 
proteins expressed on the surface of hematopoietic and lymphatic cells [118]. 
They include Lynx (Ly-6 neurotoxin) proteins encoded by lynx1 [119, 120] and 
lynx2 [121] genes expressed in murine nervous system. In addition, extracellular 
domain of the human complement regulatory protein CD59 [122], bone 
morphogenetic protein IA [123], type II activin receptor [124] and domains from 













Figure 1.6 ‘3FTx fold’ in non-venom proteins. (A) BMP receptor ecto-domain 
(1ES7; Homo sapiens), (B) complement regulatory protein CD59 (1ERG; H. 
sapiens), (C) urokinase plasminogen activator (uPAR) receptor (1YWH; H. 




The non-mammalian sources of ‘3FTx fold’ are: skin secretions like xenonin 1 
(Xenopus laevis) in amphibians [127, 128], pheromones like Plethodontid 
Modulating Factor (PMF) in salamander [129], plasma protein like trout toxin 1 
in rainbow trout [118] and a few plant lectins like wheat germ agglutinin [130] 
and hevein from plants [131]. The functional diversity of the ‘3FTx fold’ from 
various sources has been summarized in Table 1.4. Interestingly, association of 
lynx1 and lynx2 genes with nAChRs and the disulfide linkage pattern similar to 
the non-conventional toxins, raise the possibility of their evolutionary relationship 
to toxic 3FTxs. It is postulated that these gene might have duplicated during the 
due course of evolution followed by recruitment into the venom gland [132]. 
Later, their descendents might have undergone accelerated evolution in the 
protein-coding regions mediated by gene duplications [133-136], leaving 
conserved only the features required for protein folding and structural integrity, 
while swapping functional residues. Additionally, 3FTxs and Ly-6 family of 
proteins have a common gene organization (Figure 1.7). This suggests that 3FTxs 
and Ly-6 proteins might have descended from a common ancestor. 
3FTx fold: molecular scaffold with multiple missions 
The ‘3FTx fold’ provides an excellent example of an extremely successful 
scaffold that has been known to perform various roles in variety of organisms 
ranging from plants to mammals (Table 1.4). Therefore, on one hand, 
understanding their structure-function relationship is a challenging task while on 









Figure 1.7 Gene organization of ‘3FTx fold’ containing protein from 
different organisms. Intron (black bars) - exon (yellow boxes) boundaries of  Ly-
6C super-family of murine proteins lynx1, mThB [118] and a SNTx cobrotoxin 
[136] are quite conserved. Mature protein is followed by GPI anchor in 

















Some of their remarkable structural features that make them a perfect candidate 
for pharmaceutical industry are: 
� These molecules possess a simple, flat leaf-shaped structure that presents the 
functional sites effectively. 
� The multiple disulfide linkages make them a thermally- and 
conformationally-stable entity.  
� The ‘3FTx fold’ can undergo drastic changes allowing incorporation of new 
functions. 
� Just by retaining the conserved Cys-pattern and few important structural 
determinants, rest of the sequence can be replaced without the loss of the 
fold to make it recognize a new target. 
� Most importantly, proteins with ‘3FTx fold’ have been known to interact 
with a wide range of molecules like GPCRs, ion channels, enzymes, 
complement factors, glycoproteins, phospholipids and carbohydrates (Table 
1.4). 
 
Nicotinic Acetylcholine Receptors (nAChRs) 
Nicotinic acetylcholine receptors (nAChRs) also known as ionotropic receptors 
are the cholinergic receptors that form ligand-gated ion channels (LGICs). These 
LGICs open or close in response to binding of a chemical messenger like 
neurotransmitters. They are present on the plasma membranes of certain neurons 
and on the postsynaptic membrane side of the neuromuscular junction in many 
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tissues of the body. They are one of the best characterized ionotropic receptors. 
They are allosteric glycoproteins of MW ~290 kDa belonging to Cys-loop super-
family of LGICs [137, 138]. The cartoon representation of nAChR is shown in 
Figure 1.8. They are made up of five homologous subunits, arranged around a 
central pore in a pseudo-symmetric axis perpendicular to the membrane [139]. 
These subunits are categorized into α and non-α types. The α-subunits constitute 
the principal component of the ligand-binding site and are characterized by two 
neighboring cysteine residues (Cys192 and Cys193) (numbered according to 
Torpedo muscular nAChR). These Cys residues are absent in non-α subunits 
(β,γ,δ,ε). The α-subunits contribute loops A, B and C to the ligand-binding site 
while non-α subunits form the complementary counterpart of ligand-binding site 
and contribute loops D, E and F of nAChRs [68, 140, 141]. All these subunits are 
of similar dimensions (maximum; 30 Å x 40 Å x 160 Å [142]) (Figure 1.8B), 
possess similar hydrophobic profile and share common organization.  
They are characterized by: 
� a cleavable signal peptide at the N-terminal region and are secreted 
� 210-220 amino acid residues large N-terminal extracellular domain 
comprised of ‘Cys-loop’ (hence placed under ‘Cys-loop’ super-family of 
LGICs) (Figure 1.8A). ACh binding site and glycosylation sites important 
for expression and secretion of the receptor [143] or in some organisms 
(e.g. mongoose [144]) the region offering resistance to α-neurotoxins 









Figure 1.8 Cartoon representation of nAChRs. (A) Single α-subunit of nAChR. 
MI-MIV are the four transmembrane domains. Only MII domain lines the ionic 
pore. (B) Five homologous subunits constituting muscle nAChR with the 
stoichiometry (α1)2βγδ (vertical section; δ-subunit is not shown). The interface 
between two subunits inhabits the ACh binding site (C) Distribution of nAChR 
subtypes (various combinations of subunits) in different tissue types are as 
follows (from left): 1. muscle or electric organ 2. neuronal (heteropentameric; two 
types of subunits) 3. neuronal (homopentameric) 4. ganglionic 5. neuronal 
(heteropentameric; four types of subunits) 6. hair cells. ACh binding site in each 





� 70 amino acid residues long transmembrane domain with four segments (19 - 
27 residues long) of hydrophobic patches namely, MI, MII, MIII and MIIV. MI 
segment governs the assembly of subunits and formation of a heterodimeric 
ligand-binding site [147]. MII segments constitute the cation channel pore that 
selectively filters the cations. MIII and MIV bear phosphorylation sites through 
which they modulate the activity of the receptor 
� a cytoplasmic region with putative phosphorylation sites (the key regulatory 
elements of the complex) [148-150] 
� a helical hydrophobic domain spanning the cell membrane 
� a short extracellular C-terminal tail present on the surface of lipid bilayer 
Although the subunits of nAChRs share a common organization a combinatorial 
assembly of homo- and hetero-pentamers generates an enormous diversity of 
receptor types (Figure 1.8C) leading to diverse pharmacological activities. This 
diversity is enhanced in magnitude by their distribution in various cell-types 
[68]. A total of 17 nAChR subunits have been identified. Out of these, α2-α7 and 
β2-β4 have been cloned in humans, while the remaining genes have been 
identified in chick and rat genomes [151-159]. Based on their tissue distribution 
they are broadly classified into two subtypes namely, muscle-type nAChRs and 
neuronal-type nAChRs. In both types of nAChRs, the subunits are quite similar 
to one another, especially in the hydrophobic regions. It has been suggested that 
all the subunits have evolved from a common ancestor of nAChRs via gene 
duplication phenomenon [160]. The α-subunits like α7, α8, α9 that can constitute 
homopentamers represent the most ancient forms. 
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Muscular type of nAChRs 
The muscular type of nAChRs was first discovered in Torpedo and Electrophorus 
in 1970. The isolation and purification of this receptor was made possible because 
of a 3FTx (Bgtx) [74, 161, 162]. Muscular-type nAChRs are found in muscle 
tissues and electric organs of certain fishes and they have also been shown to be 
present on the surface of murine lymphocytes [163]. They assist in the 
neurotransmission followed by contraction of muscles facilitated by a series of 
events taking place at neuromuscular junction (Figure 1.9). It is a pentameric 
complex of four different subunits named as, α, β, γ and δ [164]. Later, it was 
found that this receptor is constituted by α1, β1, δ, and γ/ε subunits (in 
embryonic/adult form) in a 2:1:1:1 ratio [165-168]. The amino acid sequences 
deduced from cDNAs obtained from various organisms [169-177] suggests that 
they are significantly homologous. To date, several studies have been conducted 
on these receptors making them one of the best characterized receptor. 
Neuronal type of nAChRs 
Neuronal type nAChRs are present in the central and peripheral nervous system. 
They are pentamers constituted by α and β subunits (Fig. 1.8C). Two identical α-
subunits and three identical β-subunits constitute the most common 
heteropentameric arrangement acquired by these receptors. The possible roles 
played by various subtypes of these receptors in contrast to the only function of 







Figure 1.9 Schematic showing the events leading to the neurotransmission 
followed by muscular contraction (A) Ultrastructure of neuromuscular junction. 
The region in box is amplified that depicts the metabolism of ACh. Opening of 
nAChR in response to ACh leads to release of Ca2+ ions from the voltage-gated 
Ca2+ channels located in sarcoplasmic reticulum (B) resulting in activation 
contractile elements. The time course of an action potential, transient Ca2+ 
concentration and contraction is shown in the inset. Pictures A and B were 
downloaded from the URLs: http://faculty.etsu.edu/currie/excitation.htm and 
http://edoc.hu-berlin.de/dissertationen/abdelaziz-ahmed-ihab-2004-09 





Table 1.5 Distribution and function of various nAChR subtypes.  
 
  
a X, Y and Z represent subunits with unknown identity. bAgonists selective for 
α4β2 function versus ganglionic function; not selective versus dopamine (DA) 
release. cAgonists selective for DA release versus α4β2 function. dn-Bgt 
(bungarotoxin) is a potent antagonist of both DA release and synaptic ganglionic 
function. e α-Bgt is a potent antagonist at α7 and muscle nAChRs. (Cyt- cytosine; 
DMAC- N-N-dimethyl acetic acid; MLA-Methyllycaconitine). The table is 






In addition, these nAChRs have been implicated in several neurodegenerative 
disorders like Alzheimer’s and Parkinson’s disease, Tourette’s syndrome, 
epilepsy [179], psychological diseases like depression [180] and nicotine 
addiction [181]. 
Receptor-ligand interface revealed by AChBP (ACh-binding protein) 
The importance of polymorphic nAChRs in cholinergic signaling and their 
implications in neurological diseases makes their natural ligands, α-neurotoxins, a 
promising source of rational drug design. Therefore, it becomes important to 
discuss the structure-function relationship of the two molecules. The structural 
studies on nAChR and AChBP have helped understand the structure-function 
relationship of toxin/ligand-binding site of nAChRs. AChBP, a soluble protein 
present in molluscan glial cells (e.g. in Lymnaea stagnalis), [182, 183] is released 
in response to ACh into the synaptic cleft and modulates the cholinergic 
transmission. The mature protein is 210 amino acid residues long and forms a 
stable homopentamer. It is homologous to the N-terminal extracellular domain of 
nAChRs, especially α-subunits, and lacks the transmembrane and intracellular 
domains (Figure 1.10). It possesses nearly all the conserved residues of nAChRs 
(including the ones involved in the ligand-binding). The crystal structure of 
AChBP (isolated from Lymnaea stagnalis (great pond snail)) solved at 2.7 Å 
resolution [184] correlates well with the structural model of nAChR of resolution 
4 Å (isolated from Torpedo marmorata (marbled electric ray)) build based on the 
basis of cryo-electron microscopy studies and protein sequences of nAChR [142, 





Figure 1.10 The three-dimensional structures of nAChR (A), AChBP alone 
(B) and in complex with α-cobratoxin (C). (A) The structural model of nAChR 
(2BG9). (A1) Ribbon diagram of the receptor (for brevity, only ligand-binding 
domain or main immunogenic region (MIR) is shown; view from the synaptic 
cleft). Trp 149 (golden) is present at the interface of two subunits. (A2) View 
parallel to the membrane plane (gray, only the front two subunits are shown at the 
interface of which the ligand binds) that demarcates the extracelluar; E and 
intracellular; I regions of the membrane and the dotted lines represent the 
approximate regions constituting the subunit-subunit interface. (A3) View parallel 
to the membrane plane. (B) The crystal structure of AChBP (1UX2) and (C) 
AChBP complexed with α-cobratoxin; red. The view along (B1,C1) and 
perpendicular (B2,C2) to the five fold axis of the protein. (B3,C3) Structure of a 





The majority of AChBP consists of β-sheeted structure along with a small α-
helical segment at the N-terminus of the protein almost similar to the N-terminal 
domain of nAChR. Additionally, AChBP binds to nAChR agonists (ACh and 
nicotine) and antagonists like d-turbocurarine, α-conotoxins (neurotoxins from 
snails) and snake venom α-neurotoxins. Therefore, co-crystallization studies on α-
cobratoxin/AChBP complex [186] (Figure 1.10C) provided insights into the 
toxin/ligand binding site present at the cleft formed by subunit-subunit interface 
of nAChR. The interaction sites deduced from the structure of AChBP-toxin 
complex perfectly correlates to the mutational binding studies of toxin on 
nAChRs and the results are summarized in Table 1.6 [187]. Until now, several 
structures of such complexes of AChBP with various ligands and α-conotoxins 
have been determined [188-190]. These studies contribute greatly to the 
understanding of nAChR-ligand interactions. 
Aim and scope of the thesis 
Snake venom components have been extensively studied and have been a source 
of basic research tools. The use of venom components is not just restricted to the 
understanding of physiological, pathological, biochemical and immunological 
processes but several components from venom have also been used as diagnostic 
tools [191-193]. So far, only a handful of the venom components have been fully 
understood. Therefore, in the forthcoming years these naturally existing ‘wonder 
molecules’ have the potential to become the lead compounds for the 









Table 1.6 Intermolecular interactions between atoms of each partner in the 
complex (within 4.5Å distance).  
 
 
Residues at the respective positions in Bgtx are in parentheses and the residues in 
Cbtx and in α7 receptor (numbers based on AChBP sequence) at which mutations 
lead to a decrease in affinity by more than five and seven fold, respectively are 






This study describes various molecular biology, genomics, proteomics, 
pharmacology and structural biology techniques to understand and characterize 
the venom components of D. coronoides. The main highlights of the study are 
(mentioned in the order of chapter description): 
� Construction of a partial cDNA library from the venom gland of D. 
coronoides and identification of new proteins in the venom  
� Comparison of venom gland transcriptome to the proteome from the crude 
venom using tandem mass spectrometry approach 
� Recombinant expression of one of the novel proteins identified from the 
cDNA library using bacterial expression system 
� Purification and refolding of the recombinant protein 
� Functional characterization of the novel protein using in vivo, ex vivo and 
in vitro pharmacological assays 
� Attempts for structural characterization of the novel protein by NMR  
� Attempts to study the regulation of gene-expression of closely related 
isoforms of the novel protein 
� Elucidation of the gene sequence of another novel 3FTx using sequence 
information from its truncated version identified in the cDNA library 
Therefore, it is hoped that the results from this study will not only 
contribute towards a better understanding of biochemical and biophysical 
properties of the venom components but also find applications in the 
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Studying snake venom composition is not only essential to devise prophylactic 
measures to tackle medical emergencies resulting from snake bite but also helps 
the annotation of the novel components hidden in this arsenal of 
pharmacologically active molecules, the venom proteins. Snake venom proteins 
have been extensively used as prototypes for the development of therapeutic 
agents and as research tools to decipher the intricate details of various 
physiological processes governed by their molecular targets. The venom from a 
single snake is a cocktail of over a few hundred different proteins and peptides 
and these proteins are categorized into a small number of super-families, each 
with a unique structure. 
In the past decades, many of the highly abundant and/or highly toxic 
proteins from snake venoms have been well characterized by various methods in 
protein chemistry or by cloning of individual genes. The advent of highly 
sophisticated proteomics tools has made possible the identification and isolation 
of less abundant and poorly studied proteins from the snake venoms. However, 
such techniques are limited by the amount of crude venom that needs to be 
investigated. Therefore, for snakes that produce scarce amount of venom, the 
construction of cDNA library from their venom glands has proven to be a boon. 
Additionally, this technique provides an estimate of relative contribution of the 
individual venom components. Until now, several groups have reported snake 
venom ESTs and the library of the snake venom proteome is rapidly expanding 
[58, 194-196]. Using this approach, not only new toxins belonging to known 
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snake venom protein families but also many other new families of toxins have 
been discovered [197, 198]. 
We attempted to decipher the venom composition from the rare snake 
Drysdalia coronoides because at present no information is available on its venom. 
We chose to construct a partial cDNA library (enriched with the venom 
components, see Methods) from its venom gland because it yields 2-3 mg venom 
per milking. This chapter describes the details of the construction of a partial 
cDNA library from the mRNA isolated from the venom gland of D. coronoides to 
search for the new proteins with the simultaneous analysis of venom composition. 
To corroborate our results from transcriptomics, we performed proteomics on its 
crude venom. Lastly, we describe the properties of novel proteins identified from 
the study. 
Materials and methods 
Reagents and kits 
 
The details of procurement of reagents and kits used for this part of the study are 
as follows: LB Broth, LB agar, oligonucletides (1st Base Pte. Ltd., Singapore), 
restriction endonucleases (Fermentas International Inc., Burlinton, Ontario, 
Canada), DNA ladders, pGEM-T Easy vector, X-gal, IPTG, ProteasMAX 
surfactant (Promega Corporation, Madison, WI, USA), gel red stain (Invitrogen 
by Life Technologies, Carlsbad, CA, USA), RNeasy Mini Kit, Gel extraction kit, 
(Qiagen, Hilden, Germany), Creator SMART cDNA library construction kit, 
SMART RACE cDNA amplification, Advantage 2 polymerase mix (Clontech, 
Mountain View, CA, USA), Gene All Exprep Plasmid Quick kit (Gene All, 
Seoul, Korea), Cleanseq sequencing cleanup magnetic beads (Agencourt 
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Bioscience, Beverly, MA) and ABI PRISM BigDye Terminator v3.1 cycle 
sequencing kit (PE Applied Biosystems, Foster City, CA). All the kits employed 
in this study were used according to the manufacturer’s instructions. Other 
chemicals including dithiothreitol (DTT), iodoacetamide, trypsin, ampicillin etc. 
and common laboratory chemicals were purchased from Sigma Aldrich, 
Milwaukee, WI, USA and 1st Base, respectively. 
Collection of venom and venom gland  
D. coronoides snake was captured in south east region of South Australia. The 
venom was milked, lyophilized and stored in -80 °C (Venom Supplies Pty Ltd., 
Tanunda, South Australia). Four days later, when the mRNA production is 
assumed to be maximal [199], the snake was euthanized and the venom glands 
were dissected and transferred to RNAlater solution (Ambion, Austin, TX, USA) 
in a ten fold ratio to the volume of the glands, and kept at -80 °C until use. 
RNA isolation and cDNA synthesis 
Total RNA was isolated from 20-30 mg of frozen venom gland tissue using 
RNeasy Mini Kit. The integrity of the total RNA was determined by 
electrophoresis on 1% (w/v) agarose gel containing 0.002% (v/v) gel red stain. 
The purity and yield of total RNA was determined by measurement of A260/280 
ratio and A260, respectively on Nanodrop (GE Healthcare, Piscataway, NJ, USA). 
A total of ~400 ng RNA was used to synthesize and amplify double stranded 
cDNA (ds cDNA) by long distance PCR (LD-PCR) using the Creator SMART 
cDNA library construction kit. For library A, small sized cDNAs were removed 
by passing the PCR products through CHROMA SPIN-400 column (gel-filtration 
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based purification) provided with the kit. Aliquots (5 µl each) of nearly ten 
fractions (50 µl each) from the column were analyzed on 1% agarose gel 
electrophoresis and fractions of size ≥200 bp were pooled, precipitated and 
dissolved in water. These ds cDNAs were cloned and sequenced (as described 
below) to obtain library A clones. We were not able to obtain cDNAs 
corresponding to high MW proteins and therefore used an alternative method. In 
this method, the PCR product was loaded on 1% agarose gel and ds cDNA 
approximately ≥750 bp was excised from the gel and purified using Gel extraction 
kit. These ds cDNAs were cloned and sequenced to obtain library B clones. 
Cloning of ds cDNA  
Purified ds cDNA was subjected to TA cloning in pGEM®-T Easy vector. The 
ligation mix was incubated at 4 °C overnight. For transformation, E. coli DH5 α 
competent cells were thawed on ice for about 15 min. Afterwards, 3 µl of the 
ligation mix was added to 50 µl of cells in a 1.5 ml eppendorf tube and placed on 
ice for 30 min. The cells were heat-shocked for 90 s at 42 °C and immediately 
placed on ice. Later, 200 µl of ice-cold LB broth was added to the cells. The 
mixture was incubated at 37 °C for 1 to 2 h with shaking at 200 rpm and plated 
(100 µl each plate) onto LB agar medium supplemented with 100 µg/ml 
ampicillin, 0.5 mM IPTG and 80 µg/ml X-gal. The plates were incubated 
overnight at 37 ° C and screened for the white colonies. 
Isolation of plasmids and verification of clones 
Individual white colonies were picked randomly and grown in 2 ml of LB 
medium containing 100 µg/ml of ampicillin. The plasmids were isolated using the 
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QIAprep spin miniprep kit.  The presence of an insert was confirmed by digesting 
the plasmids with Fast Digest EcoRI. Briefly, ~100 ng of vector, 0.5 µl of enzyme 
and 1µl 10X Fast Digest buffer were mixed and the total volume was raised to 20 
µl with autoclaved water. The digestion mix was incubated at 37 °C for 30 min 
followed by analysis on 1% (w/v) agarose gel electrophoresis.  
cDNA sequencing  
The inserts (≥200 bp) were sequenced from both ends with primers specific for 
T7 and SP6 promoter sequences using the ABI PRISM BigDye Terminator v3.1 
cycle sequencing kit. Briefly, 200 ng of plasmid DNA was mixed with 1.5 µl Big 
Dye and 0.5 µl T7 or SP6 primers (10 mM stock) and the total reaction volume 
was raised to 5 µl. The PCR plate was spun briefly at 1500 rpm for 1 min to allow 
the reaction components to settle. The three-step thermal cycling parameters were 
as follows: hot start at 94 °C /1 min followed by 25 cycles of 94 °C/1 min 
(denaturation), 50 °C/5 s (annealing), 60 °C/1 min (extension) and a final 
extension of 60 °C/4 min. The amplified products were cleaned using CleanSeq 
magnetic beads. Typically, 5 µl of beads and 30 µl of 80% ethanol were added to 
the PCR product and the beads were allowed to settle on magnetic plate. The 
beads were washed with 80% ethanol for 15 min twice. The PCR plate was 
allowed to air dry followed by suspension of beads in 40 µl of autoclaved water. 
The plate was covered and vortexed followed by brief spin at 1500 rpm for 1 min. 
The sequencing reaction was carried out by loading the plate on an automated 




The nucleotide sequences were read using Chromas Lite and Gene Runner. 
Adaptor primer sequences were manually trimmed followed by determination of 
the derived amino acid sequences corresponding to the various cDNA clones. 
Putative functions of the proteins encoded by these sequences were predicted by 
BLAST search against the non-redundant database of NCBI. The sequences were 
then aligned using DNAMAN 4.15 (Lynnon Corporation, Montreal, Quebec, 
Canada) and online server ClustalW followed by manual adjustments to obtain 
the best possible alignment. The overall strategy used for the construction and 
analysis of cDNA library is depicted as schematic in Figure 2.1. 
3’RACE of venom proteins 
Total RNA (~300 ng) was used to synthesize 3’RACE libraries using SMART 
RACE cDNA amplification kit. For three finger toxins (3FTxs) and 
phospholipases A2 (PLA2s), gene-specific 3’RACE primers were designed from 
the signal sequence encoding region of 3FTx2A and PLA2147A, respectively 
obtained in the cDNA library. For snake venom metalloproteases (SVMPs) and 
vespryns, the primers were designed from the signal sequence of stephensease-1 
(ABQ01135) from Hoplocephalus stephensii and 5’UTR of ohanin (DQ103590) 
from Ophiophagus hannah, respectively. Two gene-specific primers, one each for 
primary and secondary PCR were designed. Secondary PCR was done using the 
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Figure 2.1. Schematic showing construction of cDNA library. Total RNA isolated from the venom gland of D. coronoides was 
used for synthesis of ds cDNA followed by the cloning, sequencing and analysis.  
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The primer sequences were: 
3FTx- 5’-GATGAAAACTCTGCTGCTGACCTTGGTGG-3’,  
3FTxnp- 5’-GCTGGTGGTGGTGACAATCGTGTGC-3’,  
PLA2- 5’-TATCCTGCTCACCTTCTGGTCCTGTTGGC-3’,  
PLA2np- 5’-GCTGGCAGTTTGTGTCTCCCTCTTGG-3’,  
Vespryn- 5'-ATGGTCATGTCCCTTTCTGCTGGCT-3',  
Vesprynnp- 5'-GGCTTCCAATTTAGTTTGAACTTCCAAC-3' and  
SVMP- 5’-GCATGATTGAAGTTCTCTTGGTAACTATATG-3.’ The primary 
PCR product of SVMP 3’RACE was a single, specific band on 1% agarose gel, 
therefore, secondary PCR was not performed. The PCR products were excised 
from the gel and subsequently purified, cloned, sequenced and analyzed by 
methods described above. 
In-solution tryptic digestion 
Lyophilized crude venom (500 �g) was dissolved in 500 �l of ammonium 
bicarbonate and precipitated with 2.5 ml of ice-cold acetone for 3 h at -20 °C. The 
pellet was brought up in 1 ml of 50 mM ammonium bicarbonate containing 20 �l 
of 1% ProteasMAX surfactant followed by reduction with 10 �l of 0.5 M DTT (at 
56 °C for 20 min) and alkylation with 27 �l of 0.55 M iodoacetamide (at RT for 
15 min in dark). Finally, the venom was subjected to digestion (at 37 °C for 3 h) 
with 18 �l of trypsin (1 �g/�l) and 10 �l of 1% ProteasMAX surfactant to 





HPLC separation and mass spectrometric analysis of tryptic peptides 
The volume of the tryptic digest was reduced to 200 µl using a Speedvac (Savant 
SC 110A). The solution was directly applied onto a 3.5 ��C18 reversed phase 
column (Agilent Zorbax 300SB; 1 mm x 150 mm) equilibrated with buffer A 
(0.1% trifluoroacetic acid (TFA) in water) attached to LC Packings Ultimate 
HPLC system (Dionex, Vernon Hills, IL, USA). Elution of the tryptic peptides 
was performed using a linear gradient of 0-95% buffer B (80 % acetonitrile 
(ACN)/0.1 % TFA in water) for 100 min at a flow rate of 40 �l/min. A total of 
120 elution fractions were manually collected and spotted onto the MALDI 
sample plate. The sample solution (0.3 �l) was mixed with the same volume of a 
saturated matrix solution (10 mg/ml α-cyano-4-hydroxycinnamic acid (Sigma 
Aldrich, Milwaukee, WI, USA) in 50% ACN/0.1% TFA) on the target plate and 
allowed to dry at room temperature. Raw data for protein identification was 
obtained on the 4700 Proteomics Analyzer (Applied Biosystems, Foster City, CA, 
USA). Both MS and MS/MS data were acquired with a neodymium-doped 
yttrium aluminum garnet (Nd:YAG) laser with a 200-Hz repetition rate. 
Typically, 1000 shots were accumulated for spectra in MS mode while 2400 shots 
were accumulated for spectra in MS/MS mode. Up to twenty of the most intense 
ion signals with signal to noise ratio above 30 were selected as precursors for 
MS/MS acquisition excluding common trypsin autolysis peaks and matrix ion 
signals. External calibration in MS mode was performed using a mixture of five 
peptides: des-Arg1-Bradykinin (m/z = 904.468), angiotensin I (m/z = 1296.685), 
Glu1-fibrinopeptide B (m/z = 1570.677), ACTH (1–17) (m/z = 2093.087) and 
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ACTH (18–39) (m/z = 2465.199). MS/MS spectra were externally calibrated 
using known fragment ion masses observed in the MS/MS spectrum of 
angiotensin I. Tandem mass spectra were searched against in-house database 
containing IPI human database and the protein sequences deduced from the ESTs 
of the D. coronoides venom gland, using the MASCOT software. The search 
parameters were set as follows: No restrictions on species of origin or protein 
molecular weight, two tryptic missed cleavages allowed, non-fixed modifications 
of methionine (oxidation), cysteine (carbamidomethylation), and pyroglutamate 
formation at the N-terminal glutamine of peptides and fragment and peptide mass 
tolerance ± 0.8 Da each. 
Molecular modeling 
Three-dimensional (3D) structures of novel 3FTxs were modeled using the online 
I-Tasser server for protein 3D structure prediction [200]. This server predicts the 
folds and secondary structure by profile-profile alignment threading techniques. 
For each protein, 2-5 models were predicted and the model with the lowest free 
energy was used for further analysis. Ribbon diagrams were created using the DS 
ViewerPro software (Accelrys Inc., San Diego, CA, USA).  
 
Results and discussion 
Transcriptome 
Construction of cDNA library 
We obtained 3.5 μg of total RNA from 30mg of venom gland tissues of 
the snake. The integrity of total RNA was confirmed using agarose gel 
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electrophoresis (Figure 2.2A). Intact rRNA bands and a smear corresponding to 
mRNA (117 ng/µl) ranging from 0.1-3 kb on 1% (w/v) agarose gel can be 
observed. No degraded product was observed at the bottom of the gel. Also, the 
purity (A260/A280, being 1.92) was sufficient to proceed with the cDNA synthesis. 
The LD-PCR product analyzed on 1% agarose gel appeared as a sharp band with 
ds cDNAs of about 500 bp as the major species and a smear above this band 
(Figure 2.2B). This suggests that the expressed sequence tags (ESTs) of high MW 
proteins are present but their expression level is quite low. Therefore, we 
constructed two separate venom gland cDNA libraries with slight modifications 
as mentioned in the Methods.  
Composition of venom gland transcriptome of D. coronoides 
A total of 901 isolated clones were randomly picked up from both the libraries 
and relative contribution of each library is described in Table 2.1. Plasmids from 
697 clones with inserts ≥200 bp were sequenced, out of which 604 clones 
produced readable sequences. These sequences were classified under different 
snake venom protein super-families and cellular transcripts based on their 
sequence similarity to the proteins in the NCBI database. Relative contribution of 
ESTs belonging to each class and their further classification based on their 
functions are depicted in Figure 2.3. Majority of these ESTs belonged to the snake 
venom proteins comprising nearly 93% of library A and 82% of library B 
attributed to the extraction of venom gland after four days of milking. We 
identified ESTs belonging to five known super-families of snake venom proteins 






Figure 2.2 Agarose gel electrophoresis (1% w/v) of RNA and ds cDNA from 
D. coronoides. (A) Lane 1: first and Lane 2: second elution fraction of RNA from 
the spin column. Majority of RNA gets eluted in the first round. Intact rRNA 
bands and a smear of mRNA can be seen. (B) Lane 1: 1 kb ladder and Lane 2; ds 




Table 2.1 Summary of the clones obtained from cDNA library of the venom 
gland of D. coronoides. 
 
Clone description Library A Library B 
Total number of clones picked 666 235 
Clones with inserts (>200bp) 514 183 
Clones with  ORF 431 173 





Figure 2.3 Venom transcripts of D. coronoides. Pie diagram represents the classification of various transcripts obtained from cDNA 
libraries A (A) and B (B). Cellular transcripts (left) are sorted by their functions and the venom transcripts (right) are categorized 
based on the superfamily to which they belong. The numbers in parentheses indicate overall abundance in the libraries, whereas 
numbers outside the parentheses indicate their abundance within cellular or venom transcripts. 
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They are: 3FTxs, Serine protease inhibitors (SPIs), Cysteine rich secretory 
proteins (CRISPs), Venom Nerve Growth Factor (VNGFs), and PLA2s 
(mentioned in the order of their relative abundance in the transcriptome). We also 
found the first member of a new family of snake venom phospholipase B (PLB) 
proteins. As described in the proteomics part of this chapter, we identified 
peptides belonging to two more super-families, namely, SVMPs and vespryns 
from the proteome. We sequenced ESTs corresponding to SVMPs and vespryns 
by constructing their 3’ RACE libraries. These ESTs were not identified in the 
cDNA library probably due to both the large size of cDNA and/or low expression 
levels because TA cloning is biased by smaller size and abundance of the 
fragment. In library B, in spite of extracting ds cDNA corresponding to ≥750 bp, 
we obtained cDNAs <750 bp probably due to their high abundance in cDNA pool 
loaded on the gel. However, there were fewer SPI clones in library B (7.6% 
versus 33% in library A) due to their smaller size (~400 bp) than 3FTx (~500 bp) 
found abundantly in library B (Figure 2.3B). 
The 3’RACE libraries of 3FTxs and PLA2s were constructed to obtain 
additional isoforms and to confirm the presence of singletons. Transcripts from 
library A, B and 3’ RACE library are designated as ‘A’, ‘B’ and ‘R,’ respectively. 
Only the isoforms which have been identified in the proteome and those with the 
significant changes in the sequence have been used for the alignments. The ESTs 
are further clustered within each family.  At least one clone representing each 
cluster was completely sequenced, while sequencing was repeated at least twice 
for all the singletons to eliminate the possibility of sequencing errors. Only full-
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length ESTs were submitted to the NCBI database with accession numbers 
FJ481928, FJ752448-FJ752490 and HM627202-HM627208. There are silent 
mutations and mutations that lead to substitutions in the signal sequence region of 
cDNA. But these mutations are not relevant for function of the mature protein and 
therefore, they are not considered for differentiation of one isoform from another 
in the following discussion.  
Three-finger toxin family 
Three-finger toxin family is a well-characterized non-enzymatic super-family of 
snake venom proteins with a characteristic ‘3FTx fold’ constituted by three 
adjacent β-sheeted loops, projecting from a globular, hydrophobic core cross-
linked by conserved intra-molecular disulfide linkages. Their functional diversity 
has been extensively reviewed in chapter 1 of the thesis. From the cDNA library 
we identified 391 3FTx ESTs which constitute the largest family of D. coronoides 
venom transcriptome. We sequenced an additional 244 ESTs from 3FTx 3’RACE. 
These ESTs are divided mainly into five groups (Figure 2.4) further categorized 
into 11 clusters and 19 singletons. The first group comprises one cluster 
represented by clone 2A (Figure 2.4A) and nine singletons 597A, 282A, 101R, 
37R, 61R, 110R, 149R, 44B and 109R. Singletons 597A and 282A possess single 
nucleotide changes when compared to the main cluster; 597A shows a deletion 
(Thr60 (ACA) to ‘_CA’), and 282A has a substitution in stop codon (TAG to 
TGG (Trp)) resulting in longer C-terminus. Singleton 101R differs from the rest 
of the isoforms of this group by a substitution of a stretch of 23 bp followed by 4 




Figure 2.4 Three-finger toxins (3FTxs) from D.coronoides. Deduced amino acid sequences of the isoforms are clustered together, 
represented by a clone from each cluster. Only the isoforms which have been identified in the proteome are shown except 101R (for 
the details of unique peptides identified from each isoform, see Supplementary Figure 3). The abundance of isoforms in the 
transcriptome is represented by the number of clones in parentheses. Signal sequences are in bold italics. Residues in dark gray 
(unconserved substitutions) distinguish them from the rest of the isoforms.  The isoforms are aligned to their closest homologue from 
NCBI database (their % identity and % similarity to the mature proteins from the transcriptome are indicated on the right). Groups A 
and B 3FTxs have eight cysteines and are closely related to SNTxs, whereas groups C to E have ten cysteines and are closely related 
to LNTxs. The functionally conserved residues important for the binding of SNTxs to muscular nAChR compared to Erabutoxin b 
(Ebx; 230845) (A and B) and LNTxs (C-E) to both neuronal and muscular nAChR compared to α-Cobratoxin (Cbtx; P01391) are 
highlighted in light gray. Lys residue of LNTxs implicated in binding to only muscular nAChRs is bold-faced. 
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These changes result in frame-shift leading to an extended C-terminus (Figure 
2.4A). Singletons 37R, 61R and 44B are a result of single nucleotide changes 
leading to substitution of Ala54 (GCA) to Val54 (GTA), Gln49 (CAA) to Arg49 
(CGA) and Thr43 (ACC) to Pro43 (CCC), respectively. Singletons 110R and 
149R possess single nucleotide changes resulting in substitution of Cys (TGC) to 
Tyr (TAC) and vice versa at positions 58 and 4, respectively. The second group 
consisting of one cluster represented by clone 342A and one singleton 434A 
differs from the first group by a deletion of eight nucleotides just before splice site 
of Exon II and Intron II resulting in the absence of three amino acid residues 
(Figure 2.4B). The singleton 434A has a conserved substitution of Leu47 (TTG) 
to Met47 (ATG). The third group (Figure 2.4C) comprising two clusters 
represented by clones 13A and 43A, and three singletons 173A, 346A and 146R 
are the longest (87 amino acid residues) 3FTx isoforms. They have an insertion of 
15 bp in exon III. The two clusters of this group differ by a single substitution of 
Pro16 (CCT) to Ser16 (TCT).  A singleton 173A differs from 13A by 
substitutions of Cys14 (TGT) to Trp14 (TGG) and Met84 (ATG) to Ile84 (ATA). 
Two other singletons 346A and 146R differ from 13A by substitution of Met84 
(ATG) to Thr84 (ACG) and Pro47 (CCC) to Ser47 (CTC), respectively. The 
fourth group consists of four clusters represented by clones 73A, 77A, 469A and 
620A, and two singletons 29B and 98R (Figure 2.4D). This group differs from the 
third group by a 3 bp deletion in exon II in addition to significant substitutions in 
the rest of the sequence. The cluster represented by clone 620A has a single 
nucleotide change substituting Tyr51 (CTA) to Cys51 (CTG). Interestingly, 
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singletons 98R and 28B appear to be hybrids of other isoforms. The fifth 
subgroup (Figure 2.4E) contains three clusters represented by clones 20A, 31A 
and 210A, and four singletons 291A, 472A, 17B and 178R. The two main clusters 
(20A and 31A) differ by a dinucleotide change resulting in the substitution of 
Arg29 (CGT) to Ala29 (GCT). A single nucleotide insertion at position 248 of 
210A cDNA leads to a frame-shit and hence a longer C-terminus. Singletons 
291A and 472A have substitutions of Cys (TGC/T) to Arg (CGC/T) at positions 3 
and 57, respectively. The other two singletons 17B and 178R possess 
unconserved substitutions of Ser11 (TCT) to Phe11 (TTT) and Tyr4 (TAC) to 
His4 (CAC), respectively. Singleton 193A has a 59 bp stretch missing at the 
boundary of exon II and exon III and may have resulted due to splicing error. First 
two groups and latter three groups, respectively show high sequence homology to 
the short-chain neurotoxin (SNTx) and long-chain neurotoxin (LNTx) class of 
3FTxs (Figure 2A-2E). 
Serine protease inhibitors  
The serine protease inhibitors of snake venoms, also called Kunitz type SPIs are 
generally 57-60 amino acids long with six conserved cysteine residues [201]. 
They belong to the bovine pancreatic trypsin inhibitor (BPTI) family [202, 203]. 
We found 158 ESTs belonging to this family in this cDNA library. They are 
mainly divided into three groups comprising seven clusters and two singletons. 
The first group (Figure 2.5A) comprises four clusters represented by clones 28A, 









Figure 2.5 Serine protease inhibitors (SPIs) from D.coronoides. Deduced amino acid sequences of SPI isoforms are clustered 
together, represented by a clone from each cluster and aligned to the mature protein sequence of their closest homologue from NCBI 
database. Only the isoforms which have been identified in the proteome are shown except 473A. The abundance of isoforms in 
transcriptome is represented by the number of clones in the parentheses. Signal sequences are in bold italics. Residues highlighted in 
dark gray (unconserved substitutions) distinguish them from the rest of the isoforms. The residues implicated for binding of α-
Dendrotoxin (α-DTx; P00980) to the potassium channel are highlighted in light gray. Lys17 of the mature protein (white font 
highlighted in black) represents P1 reactive site residue of trypsin inhibitor. The homologues are superbin-2 (B5KL39) and Superbin-4 




The clusters represented by clone 42A and 239A differ from 28A by a single 
nucleotide change leading to substitution of Cys 57 (TGT) to Arg 57 (CGT) and 
Lys1 (AAG) to Glu1 (GAG), respectively. The second group (Figure 2.5B) 
comprising two clusters represented by clones 87A and 373A, and one singleton 
473A differ from the first group in a few amino acid substitutions almost at the 
middle of the protein sequence. The cluster represented by clone 373A differs 
from 87A by substitutions of Met50 (ATG) to Ile50 (ATA) and Glu59 (GAA) to 
Ala59 (GCA). Singleton 473A differs from 373A by a 34 nucleotide deletion 
leading to frame-shift and an extended C-terminus (Figure 2.5B) like 3FTx 101R 
(Figure 2.4A). Third group comprises single cluster represented by clone 18A 
(Figure 2.5C). The presence of Lys at position 17 of mature protein represents P1 
reactive site residue of trypsin inhibitor. Although there are SPIs with Asn17 but 
its impact on the protease inhibition has not been determined. The sequence 
information reveals that these isoforms are closely related to protease inhibitors 
than to neurotoxins like α-DTx (Figure 2.5).  
Cysteine-rich secretory proteins (CRISPs) 
Cysteine-rich secretory proteins are extensively distributed in mammals, reptiles, 
amphibians and secernenteans. They are highly conserved ~20-30 kDa proteins, 
organized in three domains- a PR-1 (Pathogenesis Related proteins of group 1) 
domain, a hinge domain and a cysteine-rich domain (CRD). They contain 16 
cysteine residues forming eight conserved disulfide bonds. A few CRISPs have 
been purified and characterized from various snake venoms. Some of them are 
known to block cyclic nucleotide-gated ion channels [43, 45] while several others 
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block potassium-stimulated smooth muscle contraction [44]. Only one cluster 
comprising four clones of CRISPs (FJ752452) was identified in library B 
accounting for 2.8% of the D. coronoides cDNA library (Figure 2.3B). 
Phospholipases A2 (PLA2s) 
They represent an extensively characterized super-family of snake venom proteins 
that play an important role in immobilization and capture of prey. These proteins 
(13-14 kDa) have 12-14 conserved cysteine residues that form six or seven 
disulfide bridges.They share a similar protein folding pattern with an α-helical 
core, a backbone loop and a β-wing [204]. Their functional diversity is well 
documented by myriads of pharmacological activities such as neurotoxic, 
cardiotoxic, myotoxic, anticoagulant, antiplatelet and edema-causing effects [26, 
205]. Only one EST (clone 147A) corresponding to PLA2 was obtained from 
library A. To identify additional isoforms, we sequenced a total of 50 clones from 
PLA2 3’RACE library. However, we found only one cluster (6 clones) 
represented by clone 22R, encoding full-length isoforms. The rest were truncated 
because of non-specific annealing of reverse primer to the stretches of ‘A’ in 
cDNAs of PLA2s. The two isoforms differ from each other by substitutions of 
Asp91 (GAT) to Ala91 (GCT) and Lys94 (AAA) to Gln94 (CAA) (Figure 2.6).  
Venom nerve growth factor (VNGF) 
They exist as ~25 kDa dimers in the venom and belong to the family of 










Figure 2.6. Phospholipases A2 (PLA2s) from D. coronoides. Deduced amino acid sequences of single PLA2 isoform from cDNA 
library and a cluster represented by clone 22R from 3’RACE library are aligned to their closest homologue from NCBI database, PLA2 
Aussup from A. superbus (AAD56559); mature protein only. The number of clones sequenced for each isoform is in the parentheses. 
Signal sequences are in bold italics and the pro-peptide sequences are italicized. Conserved Asn49 (highlighted in black with white 
font) of the mature protein suggests that they are enzymatically active. Amino acid residues constituting calcium binding loop are 
boxed while catalytic helix C is in bold-face. 
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They have been classified into four groups: group I and II VNGFs are non-
covalent homodimers, group III VNGFs are disulfide linked homodimers and 
group IV VNGFs are heterodimers with two subunits (γ and β). Group II VNGFs 
are glycosylated and exist as ~35 kDa proteins. Recent studies on the VNGF 
isolated from Naja kaouthia suggest that they act as metalloprotease inhibitors 
[51]. We obtained only one cluster comprising two clones corresponding to 
VNGF (HM627208). D. coronoides VNGF is predicted to have a glycosylation 
site (NFT) at position 40 of the mature protein.  
Phospholipase B (PLB); a new family of snake venom proteins 
Phospholipase B (PLB) found in snake and bee venoms [207-209] is known to 
cause hemolysis. They exist as both monomeric and dimeric forms with MW ~16 
kDa and 35 kDa, respectively [208]. We found only one EST in cDNA library B 
which is similar to putative PLB belonging to new lipase family (Figure 2.7) 
present in mammals, flies and nematodes but its function is not known [210]. D. 
coronoides PLB (FJ752451) has a signal sequence of 36 amino acid residues and 
the protein has an expected MW of about 60 kDa (excluding three putative 
glycosylation sites). We also found peptides corresponding to this EST in the 
crude venom of this snake (see below). This is the first report of a PLB sequence 
obtained from any snake venom transcriptome so far and it represents first 





Figure 2.7 Phospholipase B (PLB) from D. coronoides. Alignment of PLB sequences of Mus musculus (Mouse; Q8BHG8), Homo 
sapiens (Human; Q8NHP8), slime mould Dictyostelium discoideum (DICTY; Q8MWQ0) and D. coronoides (DRYS; FJ752451). 
Signal sequence (bold italics), identical residues (shaded dark gray) and similar residues (shaded light-gray) are shown. The consensus 
lipase sequence GXSXG (white font, shaded light-gray in the mouse and human isoforms) and highly conserved region of PLBs; 
NSGTYN(N/S)Q (white font, shaded black) are also indicated. 
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Snake venom metalloproteases (SVMPs) 
Snake venom metalloproteases have highly variable MW due to differential 
retention of domains during post-translational modifications leading to their 
classification into three major groups namely, PI, PII and PIII [211]. They have a 
common zinc binding site with a consensus sequence of HEXXHXXGXXH 
[212]. The broad spectrum of their functions including hemorrhagic [213, 214], 
local myonecrotic [215], antiplatelet [31], edema-inducing and other 
inflammatory effects [32, 216]. We did not find clones encoding SVMPs in the 
two partial cDNA libraries of D. coronoides examined. However, we found 
several peptides corresponding to SVMPs in our proteomics studies (see 
proteomics section). Therefore, we constructed 3’RACE library and sequenced a 
total of 10 clones. Four full-length clones were sequenced completely comprising 
one cluster and two singletons (Figure 2.8). They belong to PIII SVMPs based on 
their domain organization.  
Vespryns 
Vespryns (Venom PRY-SPRY domain-containing proteins) are a recently 
identified family of proteins. Only a few proteins belonging to this family have 
been identified until now [58, 217, 218]. One of the members of this family, 
ohanin is well characterized and is known to induce hypolocomotion and 
hyperalgesia in mice [49]. We sequenced 16 clones from vespryn 3’RACE library 
and obtained four full-length singletons. Only one singleton (HM627207) was 






Figure 2.8 Snake venom metalloproteases (SVMPs) from D. coronoides. Deduced amino acid sequences of SVMP isoforms from 
3’RACE library are aligned to their closely related isoform from NCBI database, caritenease-1 (ABQ01132) from T. carinatus; 
mature protein only. Signal sequences are in bold italics. The inter-domain segments are boxed (solid border) and various domains of 
the precursor protein are represented as follows: pro-domain; light gray, metalloprotease domain, italicized; disintegrin domain, dark 
gray and cysteine-rich domain, black. The Zn2+ binding region in the metalloprotease domain is in dashed-box. The conserved loop 
(shown as white font in dark gray) found in ADAMs (a disintegrin and metalloproteinase) is also shown. Residues highlighted in light 





From the transcriptome, we obtained several venom ESTs that encode proteins 
with odd number of cysteines that might perturb the structural fold, characteristic 
of each snake venom protein super-family. Also, a few isoforms had single 
nucleotide changes like insertions/deletions leading to frame-shift resulting in a 
longer or shorter protein and conserved or unconserved substitutions. Most of the 
isoforms exhibiting such changes are present as singletons may have appeared 
due to PCR error rather than their true existence or may represent pseudogenes. 
Therefore these isoforms were not used for alignments. 
Cellular transcripts 
In addition to the venom transcripts, other cellular transcripts constituted 6.4% of 
library A represented by polyadenylated 18S and 28S rRNAs, and partial 
sequences of metabolic proteins (Figure 2.3A). However, in addition to such 
sequences in library B, ESTs belonging to a variety of house-keeping genes were 
obtained (Figure 2.3B), together constituting a total of 14% to the library B. Most 
of the transcripts were found as singletons encoding venom gland cyclophilin, 
signal sequence beta translocon, GTP binding protein, NADH subunit I, 
cytochrome oxidase c subunit I, parvalbumin beta, programmed cell death 
protein, mitochondrial ribosomal protein, ribosomal protein 40, signal peptidase, 
troponin T, transposon (SINE9) and two ESTs corresponding to troponin 1, 
translation IF 1A and interferon gamma inducible lysosomal thiol reductase 
(GILT). This is the first report of snake GILT (FJ752453; Figure A.1 in 
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Appendix.), which shows 60% identity and 71% similarity to a mammalian-GILT 
from platypus Ornithorhynchus anatinus (XP_001511104).  
Unknown and hypothetical proteins 
Transcripts encoding unknown and hypothetical proteins constituted 2.3% and 
1.7%, respectively of library B (Figure 2.3B). None of these proteins have signal 
sequence, a pre-requisite for a venom protein to be secreted into the venom gland 
lumen. Therefore, they may represent some cellular components. Their 
bioinformatics analysis showed either poor or no match to BLASTp as well as 
BLASTn.  
Proteomics of crude venom of Drysdalia coronoides 
The overall complexity of D. coronoides venom was determined by SDS-PAGE 
under reducing and nonreducing conditions (Figure 2.9). The electrophoretic 
profile shows that the venom is rich in proteins ranging from ~6 to 10 kDa 
corresponding to SPIs and 3FTxs. The protein bands at ~22 and 64 kDa may 
correspond to CRISPs and SVMPs, respectively. To confirm the presence of 
proteins found in the transcriptome and to search other proteins expressed by the 
venom gland, we performed proteomics on the crude venom of D. coronoides. 
MS/MS data of tryptic peptide fractions (Figure 2.10) were searched against our 
in-house database containing 45 sequences deduced from venom transcriptome 
and IPI human database. The peptides with MASCOT score >30 were used as a 
cutoff for the presence of a protein isoform in the venom (Table A.1 in 
Appendix). Once the presence of a specific protein in the venom is confirmed, the 









Figure 2.9 SDS-PAGE analysis of D. coronoides venom. Samples were 
electrophoresed in Tris-glycine (4-20%) resolving gel and stained with Coomassie 
Brilliant Blue R250. Nonreduced (NR) and reduced (R) samples were run along 






 Figure 2.10 RP-HPLC profile of tryptic digest of the crude venom of D.coronoides. The crude venom (500 �g) after trypsin 
digestion was loaded on Jupiter C18 column equilibrated with buffer A (0.1% TFA in water) attached to LC/MS/MS system. The 
fractions were eluted at a linear gradient of 0-95% buffer B (80% ACN + 0.1% TFA in water) with a flow rate of 40 µl/min. The 
elution profile has been zoomed to show peaks collected collected for MALDI. 
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(but not to IPI human database) with MASCOT scores range between 20 and 30, 
whose MS/MS spectra have been manually inspected with the majority of the 
peaks assigned, were also included as the peptides identified for the particular 
venom protein. We identified proteins from five super-families of snake venom 
proteins, namely, 3FTx, SPI, CRISP, PLA2 and PLB (may represent a new family, 
as mentioned earlier) whose transcripts were sequenced from the cDNA library. 
The presence of VNGF in the venom could not be confirmed. 
 The sequence coverage for various proteins ranged from 91.5% 
(SPI161A) to 4.3% (PLB) (Figure 2.11) and depends on pronounced differences 
in their sequence and hence the tryptic fragmentation as well as post-translational 
modifications. When Lys and Arg residues are closer to each other, the tryptic 
peptides are too short to be detected as the lower molecular mass cutoff was set at 
800 Da to avoid matrix interference. In contrast, when Lys and Arg residues are 
too far apart, the tryptic peptides are too long to be detected as the higher 
molecular mass cutoff was set at 3500 Da. However, in the case of 3FTx2A, the 
most abundant transcript with 130 clones, we could not identify the 23 amino acid 
residue long N-terminal peptide. As the size of this peptide falls within the 
experimental range, it is not clear whether its conspicuous absence could be due 
to ion suppression in MALDI. Despite the lower abundance (2 clones) in the 
transcriptome, we were able to identify 3FTx342A indicating the sensitivity of the 
proteomics approach. For some 3FTxs, such as 3FTx31A, the sequence coverage 
was 82%, while others, such as 3FTx43A and 3FTx13A, show only 56% 







Figure 2.11 Schematic representing the sequence coverage of the proteins 





Figure 2.11 (Continued)… 
Protein sequences are represented by black bars while blue bars refer to tryptic 
peptides of the corresponding protein identified by tandem mass spectrometry. 
Dashed blue bars represent the segments with MASCOT score <30. Red bars 
represent regions flanked by or having Arg and/or Lys residues resulting in 
segments too short to be identified. Green bars refer to segments that are too large 
to be identified by the experimental parameters used (MW cut off; 800Da-3500 
Da). The green bar in 3FTx43A distinguishes it from 3FTx13A with identical 
tryptic fragmentation. The proteins with multiple domains (CRISP and SVMP) 
are represented by domain name at the top. Putative glycosylation sites (predicted 
from online server NetNGlyc) are marked by pink arrow. Left panel shows the 
annotation of the protein with sequence coverage in brackets. Length of proteins 




could be identified. The former has Arg in the unique peptide (resulting in shorter 
fragments) and the latter shares high sequence identity to other LNTx isoforms. 
However, both of them were considered to be present because of their reasonable 
abundance in the transcriptome. Although nearly complete sequence coverage 
was found for the major isoforms of SPI, the sequence coverage for SPI18A was 
only 61% due to the presence of Arg and Lys residues in the C-terminus. The 
MASCOT data for PLA2s of D. coronoides, PLA2147A and PLA222R, reveal 
sequence coverage between 67% and 69%, respectively. Phospholipase B (two 
peptides) and CRISP (five peptides) show low sequence coverage of 3 and 10%, 
respectively. Identification of two PLB peptides with MASCOT scores of 65 and 
31 suggests its presence in the venom. Several ESTs including unique singletons 
and hybrid clones were not identified probably due to their presence below 
detection limits and/or absence of unique peptides, respectively.  
 MASCOT search of tandem MS peaks against non-redundant NCBI 
database identified peptides corresponding to two more snake venom super-
families namely, SVMPs and vespryns. Therefore, we constructed 3’RACE 
libraries to obtain complete sequences of these proteins and the search was 
repeated with a new database constituting these sequences exclusively. The 
second search resulted in the higher sequence coverage compared to the previous 
one due to the presence of sequences unique to D. coronoides SVMPs and 
vespryns. The lower sequence coverage of SVMPs (13-28%) compared to other 
venom proteins could be due to larger or smaller fragments, glycosylated peptides 
or ion-suppression effect. A peptide predicted to be glycosylated (in SVMP9 and 
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SVMP8) was identified without carbohydrate moiety by MS/MS, indicating that 
the site is either not glycosylated or only partially glycosylated. Interestingly, we 
identified a peptide with a high MASCOT score (91) corresponding to pro-
peptide region (Figure A.2 in Appendix). Generally, this region is believed to be 
cleaved off during maturation but in a few reports, some peptides from this region 
have been found in the venom [219, 220]. It is speculated that the pro-peptide 
may represent a part of misfolded protein that failed to enter trans-Golgi network 
and released into the venom gland lumen along with the mature protein containing 
vesicles from Golgi-network [211]. For vespryns also, a second search resulted in 
moderate sequence coverage (34.5%; previously 6.8%) due to interruption of 
sequence by Arg and Lys residues at several places.  
Description of novel proteins  
We have obtained sequences of a variety of 3FTxs similar to postsynaptic toxins 
binding to nAChRs and most of them have all functionally important residues 
involved in binding to nAChR (Lys23, Trp25, Asp27, Phe29, Arg33, Arg66 and 
Lys35 in LNTx class [221] and Ser8, Gln10, Lys27, Trp29, Asp31, Arg33 and 
Lys47 in SNTx class, respectively) (Figures 2.3A-2.3E) [222, 223].  However, 
there are three clusters appearing distinct from canonical toxins.  
A cluster represented by clone 3FTx13A, the longest 3FTx (87 aa) (Figure 
2.4C) has an extended C-terminus, which is predicted to form an α-helix (yellow) 
(Figure 2.12B). It also has unconserved substitutions of functionally important 
residues, such as Arg36, Arg33 and Phe29. The presence of Ala and Leu instead 







Figure 2.12 Comparison of three-dimensional structural models of the novel 
proteins to the crystal structures of α-Cobratoxin (Cbtx) and erabutoxin 
(Ebx).  (A) and (D) are crystal structures of Cbtx (PDB code 2ctx) and Ebx (PDB 
code 3Ebx), respectively while (B) and (E) are modeled structures of 3FTx13A 
and 3FTx 342A, respectively. (C) and (F) are superposed (A) and (B), and (D) 
and (E), respectively. The amino acid residues variable in the crystal structure and 
structural model are shown in ball and stick model.  
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The mutational studies on LNTx, α-cobratoxin demonstrate the decrease in 
binding constant by a factor of 7.4, 767 and 12, respectively when Arg36, Arg33 
and Phe29 were mutated to Ala, Glu and Leu, respectively [221]. The side chains 
of both Phe29 and Arg33 position the toxin in the ligand-binding pocket by 
establishing hydrophobic and aromatic interactions with the active site residues 
present in the ligand binding domain of AChBP with ligand-binding domain 
homologoues to muscle nAChR; Figure 1.10) [186]. Therefore, a detailed 
characterization of this protein is warranted considering these substitutions and 
the abundance of this isoform in the transcriptome. In addition, there are no 
reports of any 3FTx carrying an α-helix at the C-terminus. 
Another novel protein is 3FTx342A (57 aa), the shortest of all SNTx 
isoforms obtained from the venom transcriptome (Figure 2.4B). In this protein, 
Ser8 is replaced by Leu, which alters the hydrophobicity of loop I (Figure 2.12E). 
It has been experimentally demonstrated that mutation of Ser8 to Gly led to 
decrease in binding constant to nAChR by a factor of 175 [222]. In addition, 
absence of Asp31 and Arg33, residues playing critical role in the recognition of 
nAChR, and altered residues at the C-terminus may significantly affect its 
pharmacology. This missing segment results in a shorter loop II in this protein as 
compared to erabutoxin (Figure 2.12F). Thus, it would be interesting to 
investigate into its pharmacology. A summary of the work done in this chapter is 









Figure 2.13 Schematic showing the summary of characterization of novel 








Cloning, Expression and 






One of the reasons for elucidation of the transcriptome of Drysdalia coronoides 
from the venom gland was that this snake yields only 2-3 mg of venom per 
milking. The venom obtained along with the snake specimen could only suffice 
for the identification of the venom components whose transcripts were obtained in 
the cDNA library. Additionally, this is a rare snake and obtaining additional 
specimens other than the two specimens whose tissues were used to carry out this 
study would not be easy. Therefore, for sustainable use of any identified novel 
protein in pharmaceutical industry would require the use of synthetic peptides or 
recombinant proteins. 
In chapter 2, we described the identification and sequence based 
characterization of long chain neurotoxin encoded by a cluster represented by 
clone 13A and was named as ‘drysdalin’. However, for further functional and 
structural characterization, the protein had to be expressed recombinantly in a 
heterologous system because no snake cell lines are available to express the 
protein in its native environment. 
Recombinant DNA (rDNA) technology has revolutionized the field of 
biological sciences and was made possible because of the universality of the 
genetic code [224] and by the discovery of restriction endonucleases by Werner 
Arber and Hamilton Smith, for which they received the Nobel Prize in medicine 
in 1978. The first organism of choice for recombinant expression is E. coli 
because of simple physiology, short generation time and high product yields. 




suitable for expression of eukaryotic proteins that require post-translation 
modifications such as formation of disulfide bonds. Presently, several bacterial 
strains and vectors are commercially available to express the protein of interest. 
Overview of pET system 
The pET system is the most robust system yet developed for cloning and 
expression of recombinant proteins in E. coli. The bacterial strain BL21(DE3) i.e. 
BL21 host strain lysogenized with lambda phage DE3 carrying a copy of gene 
encoding T7 RNA polymerase, is the commonly used strain for the expression of 
foreign genes. Figure 3.1A describes how pET system works. Typically, a cDNA 
sequence whose protein product has to be expressed is cloned in a pET plasmid 
carrying a selectable marker. Host cells, BL21 (DE3) or their derivatives are 
transformed with pET plasmid. The expression of the protein is induced by †IPTG 
(Isopropyl β-D-1-thiogalactopyranoside) [225]  allowing host cell to express T7 
RNA polymerase under the control of lacUV5 promoter. In an induced state, T7 
RNA polymerase is so selective and active that almost all of the host cell’s 
resources are diverted to the expression of target gene such that the desired 
product can comprise more than 50% of the total cell protein a few hours after 
induction. Sometimes, even in the absence of IPTG, basal expression of target 
gene (also called ‘leaky expression’) takes place because of T7 RNA polymerase 
expression from lacUV5 promoter in λDE3 lysogens, which may be toxic to the 
host cell (any recombinant protein may interfere with the normal cell function).  
                                               
† A synthetic analogue of allolactose (triggers transcription from lac operon). By fine tuning the 





Figure 3.1 Overview of pET systems. (A) The host strain BL21 (DE3) 
transformed with recombinant pET plasmids containing a lac operator sequence 
just downstream of the T7 promoter, a natural promoter and a coding sequence for 
the lac repressor (lacI), oriented in opposite directions. IPTG induction allows 
host cell to express T7 RNA polymerase. The lac repressor acts both at the 
lacUV5 promoter and T7lac promoter repressing the transcription of the T7 RNA 
polymerase gene (in host) and the target gene (from plasmid), respectively. (B) 
The host strain (transformed with T7 plain promoter) carrying a plasmid for T7 
lysozyme, strategy to prevent leaky expression. The figures haves been adapted 
from pET manual available on Novagen website. 
 
